Other secondary syphilis of skin
ICD-10 A51.39 is a billable code used to indicate a diagnosis of other secondary syphilis of skin.
Secondary syphilis is a stage of syphilis that occurs after the primary stage, characterized by systemic dissemination of the Treponema pallidum bacterium. Other secondary syphilis of skin refers to skin manifestations that do not fall under the typical presentations of secondary syphilis, such as mucous membrane lesions or generalized rash. Clinically, patients may present with various skin lesions, including papules, plaques, or other atypical rashes that can be mistaken for other dermatological conditions. The lesions are often accompanied by systemic symptoms such as fever, malaise, and lymphadenopathy. Diagnosis is confirmed through serological testing, including non-treponemal tests (e.g., RPR, VDRL) and treponemal tests (e.g., FTA-ABS). Treatment typically involves benzathine penicillin G, which is effective in eradicating the infection. It is crucial for healthcare providers to conduct thorough contact tracing to identify and treat sexual partners to prevent further transmission of the infection.
Detailed clinical notes on symptoms, serological test results, and treatment plans.
Patients presenting with atypical skin lesions and systemic symptoms.
Ensure thorough documentation of contact tracing efforts and patient education on STI prevention.
Comprehensive descriptions of skin lesions, including size, shape, and distribution.
Patients with skin lesions that may mimic other dermatological conditions.
Differentiation from other skin conditions is crucial for accurate coding.
Used to confirm diagnosis of secondary syphilis.
Document test results and clinical correlation.
Infectious disease specialists should ensure comprehensive testing.
Common symptoms include a rash, fever, sore throat, and swollen lymph nodes. Skin lesions may vary in appearance.
Diagnosis is made through clinical evaluation and serological testing, including both non-treponemal and treponemal tests.
